The largest database of trusted experimental protocols

Moe version 2008

Manufactured by Chemical Computing Group
Sourced in Canada

MOE version 2008.10 is a software application for molecular modeling and drug design developed by Chemical Computing Group. It provides tools for structure-based and ligand-based drug design, including molecular visualization, molecular mechanics, and cheminformatics capabilities.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using moe version 2008

1

Molecular Docking Study of CDK8/CycC Enzyme

Check if the same lab product or an alternative is used in the 5 most similar protocols
Molecular Operating Environment (MOE version 2008.10) by Chemical Computing Group (CCG) was used for the docking studies (Inc. CCG, 2016 ). The protein preparation steps involved 3D protonation, energy minimization, and active site identification. The X-ray crystallographic structure of CDK8/CycC enzyme co-crystallized with Senexin A (PDB code 4f7s) was obtained from the Protein Data Bank (Schneider et al., 2013 (link)). The enzyme was prepared for virtual docking studies where: (i) the ligand molecule with any existing solvent molecules were removed. (ii) Hydrogen atoms were added to the structure with their standard geometry. To visualize the binding pocket, alpha spheres were created followed by the generation of dummy atoms on the centers of these spheres. The pocket was found to be a deep cavity lined with the amino acid residues including both hydrophobic and hydrophilic amino acids. Energy minimization tool MOPAC 7.0 was applied for the tilted compounds. (iii) MOE Alpha Site Finder was used for the active sites search and dummy atoms were created from the obtained alpha spheres. The obtained ligand-enzyme complex model was then used in calculating the energy parameters using MMFF94x force field energy calculation and predicting the ligand-enzyme interactions.
+ Open protocol
+ Expand
2

Docking Studies of Enoyl Reductase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Docking studies for the synthesized products were performed using Molecular Operating Environment (MOE) version 2008.10 (Chemical Computing Group Inc., Montreal, QC, Canada). Compounds 5ae were built using the builder interface of the MOE program and subjected to energy minimization using the included Forcefield MMFF94x calculations. The X-crystallographic structure of E. coli Enoyl reductase (PDB ID: 1LXC) which is complexed with ((E)-3-(6-aminopyridin-3-yl)-N-methyl-N-((1-methyl-1H-indol-2-yl)methyl) acrylamide (PDB ID: AYM)) (NAD), that was obtained from Protein Data Bank.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!